Is 2C-I legal in United Arab Emirates?

Legal status

2C-I is printed in Schedule 5 of Decision No. 158 of 2025, in the phenethylamines block at item 25, subitem 9. The entry «2C-I؛ 4-يودو-2،5-ثنائي ميثوكسي فينيثيل أمين» names the compound and its 4-iodo-2,5-dimethoxy description, and the dossier renders the chemical name as 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine. Subitem 9 should be read against subitem 17 of the same block, which carries 25I-NBOMe: the schedule controls the iodinated 2C compound and its N-benzyl derivative as two separate enumerated entries, so neither is reached through the other and a substance proved to be one is not answered with the placement of the other. Schedule 5 is the first psychotropic schedule, so this row runs through Articles 10, 41 and 57, with Schedule 10 group 1 carrying the quantity band. The placement was read on 20 September 2026.

Consequences if caught

Item 25, subitem 9 of Schedule 5 puts 2C-I inside one of the four schedule groups Article 57 names. The dossier records Article 57 as stating mandatory death for its trafficking or promotion trigger and as naming no quantity, so nothing about weight has to be established for the capital route to be engaged on this row. Schedule 10 does give this substance a group 1 band, and the dossier records that the Schedule 10 bands do not gate Article 57, which means the band cannot be quoted as a death threshold without inventing a threshold the article does not contain. Article 41 is the personal use route the dossier attaches to this branch and its tariff is not stated, so no figure for personal possession is given here either.

If prescribed or medical

The dossier's single country level traveller handle is recorded at the modafinil row: a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: 2C-I is at Schedule 5, item 25, subitem 9, a research chemical placement with no medicinal product recorded behind it. No prescribing route, permit or exemption appears for it anywhere in the dossier, so the medical question is deferred rather than constructed from the schedule branch.

Documentation

Nothing is recorded that would document lawful carriage of 2C-I. The dossier holds the subitem 9 placement and no medical route at all, so this row has no prescription, permit or declaration procedure to describe. Provenance: the entry «2C-I؛ 4-يودو-2،5-ثنائي ميثوكسي فينيثيل أمين» at item 25, subitem 9 was read on 20 September 2026, and the capital analysis rests on Article 57 rather than on the group 1 band.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.